{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:03Z","timestamp":1791357483797,"version":"4.3.1"},"reference-count":129,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,20]]},"DOI":"10.3109\/10673229.2011.614483","type":"journal-article","created":{"date-parts":[[2011,9,15]],"date-time":"2011-09-15T13:03:06Z","timestamp":1316091786000},"page":"240-258","source":"Crossref","is-referenced-by-count":66,"title":["The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Posttraumatic Stress Disorder"],"prefix":"10.1097","volume":"19","author":[{"given":"Laura A.","family":"Bajor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Nectara","family":"Ticlea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Osser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.smrv.2007.09.003","article-title":"Sleep-specific mechanisms underlying posttraumatic stress disorder: integrative review and neurobiological hypotheses.","volume":"12","author":"Germain","year":"2008","journal-title":"Sleep Med Rev"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archgenpsychiatry.2009.205","article-title":"Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder.","volume":"67","author":"Wang","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3928\/0048-5713-19990501-10","article-title":"Algorithms for the pharmacotherapy of anxiety disorders in patients with chemical abuse and dependence.","volume":"29","author":"Osser","year":"1999","journal-title":"Psychiatr Ann"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3928\/00485713-20051101-04","article-title":"A new treatment algorithm for posttraumatic stress disorder.","volume":"35","author":"Davidson","year":"2005","journal-title":"Psychiatr Ann"},{"issue":"2","key":"R9-3-20210129","first-page":"CD003388","article-title":"Psychological treatment of post-traumatic stress disorder (PTSD).","author":"Bisson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10673220802277904","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.","volume":"16","author":"Hamoda","year":"2008","journal-title":"Harv Rev Psychiatry"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/10673220903523524","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on bipolar depression.","volume":"18","author":"Ansari","year":"2010","journal-title":"Harv Rev Psychiatry"},{"key":"R14-3-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.IDT.0000391328.04097.1e","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on generalized social anxiety disorder.","volume":"45","author":"Osser","year":"2010","journal-title":"Psychopharm Rev"},{"key":"R16-3-20210129","first-page":"517","article-title":"Fluoxetine in posttraumatic stress disorder.","volume":"55","author":"van der Kolk","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4088\/JCP.v68n0508","article-title":"Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting.","volume":"68","author":"Friedman","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/da.20292","article-title":"Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder.","volume":"25","author":"Strawn","year":"2008","journal-title":"Depress Anxiety"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.55.10.913","article-title":"Posttraumatic stress disorder and drug disorders: testing causal pathways.","volume":"55","author":"Chilcoat","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"RU20-3-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.1996.03530340025025","article-title":"A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression.","volume":"275","author":"Mason","year":"1996","journal-title":"JAMA"},{"key":"RU21-3-20210129","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1399-5618.2004.00151.x","article-title":"Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies.","volume":"6","author":"Otto","year":"2004","journal-title":"Bipolar Disord"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1017\/S1461145706006596","article-title":"Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features.","volume":"10","author":"Kozaric-Kovacic","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"RU23-3-20210129","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0006-3223(00)00933-1","article-title":"A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection.","volume":"48","author":"Breslau","year":"2000","journal-title":"Biol Psychiatry"},{"key":"RU24-3-20210129","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jts.20372","article-title":"Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD.","volume":"21","author":"Gill","year":"2008","journal-title":"J Trauma Stress"},{"key":"RU25-3-20210129","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00213-006-0367-6","article-title":"A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: a preliminary study.","volume":"186","author":"Rasmusson","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archpsyc.58.5.485","article-title":"Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.","volume":"58","author":"Davidson","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"RU27-3-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0010-440X(03)00111-1","article-title":"Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.","volume":"44","author":"Brady","year":"2003","journal-title":"Compr Psychiatry"},{"key":"R28-3-20210129","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1176\/appi.ajp.158.12.1982","article-title":"Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study.","volume":"158","author":"Marshall","year":"2001","journal-title":"Am J Psychiatry"},{"key":"RU29-3-20210129","first-page":"132","article-title":"Impact of childhood trauma on treatment outcome in the treatment for adolescents with depression study (TADS).","volume":"49","author":"Lewis","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"RU30-3-20210129","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/NMD.0b013e3181b3afaa","article-title":"A review of dissociative disorders treatment studies.","volume":"197","author":"Brand","year":"2009","journal-title":"J Nerv Ment Dis"},{"key":"R31-3-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/da.20176","article-title":"A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults.","volume":"24","author":"Marshall","year":"2007","journal-title":"Depress Anxiety"},{"key":"RU32-3-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1056-4993(02)00103-7","article-title":"Dissociative symptoms in posttraumatic stress disorder: diagnosis and treatment.","volume":"12","author":"Steiner","year":"2003","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"RU33-3-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00404-007-0433-2","article-title":"Psychotropic medication during pregnancy and lactation.","volume":"277","author":"Menon","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"RU34-3-20210129","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.addbeh.2008.05.007","article-title":"Smoking in help-seeking veterans with PTSD returning from Afghanistan and Iraq.","volume":"33","author":"Kirby","year":"2008","journal-title":"Addict Behav"},{"key":"RU35-3-20210129","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ntr\/ntp123","article-title":"Influence of PTSD symptom clusters on smoking status among help-seeking Iraq and Afghanistan veterans.","volume":"11","author":"Cook","year":"2009","journal-title":"Nicotine Tob Res"},{"key":"RU36-3-20210129","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004714-200102000-00017","article-title":"A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder.","volume":"21","author":"Hertzberg","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R37-3-20210129","first-page":"169","article-title":"Disturbed sleep in post-traumatic stress disorder: secondary symptom or core feature Sleep Med R","volume":"12","author":"Spoormaker","year":"2008","journal-title":"ev"},{"key":"R38-3-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/NMD.0b013e3181961d8e","article-title":"Impact of sleep disturbances on PTSD symptoms and perceived health.","volume":"197","author":"Belleville","year":"2009","journal-title":"J Nerv Ment Dis"},{"key":"R39-3-20210129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/jts.20351","article-title":"Nonnightmare distressed awakenings in veterans with posttraumatic stress disorder: response to prazosin.","volume":"21","author":"Thompson","year":"2008","journal-title":"J Trauma Stress"},{"key":"R40-3-20210129","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1176\/ajp.155.7.929","article-title":"Sleep disturbances in the Vietnam generation: findings from a nationally representative sample of male Vietnam veterans.","volume":"155","author":"Neylan","year":"1998","journal-title":"Am J Psychiatry"},{"key":"R41-3-20210129","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.biopsych.2003.12.018","article-title":"Heart rate variability during sleep and the early development of posttraumatic stress disorder.","volume":"55","author":"Mellman","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R42-3-20210129","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.ajp.160.2.371","article-title":"Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.","volume":"160","author":"Raskind","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R43-3-20210129","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","article-title":"A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.","volume":"61","author":"Raskind","year":"2007","journal-title":"Biol Psychiatry"},{"key":"R44-3-20210129","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4088\/JCP.v68n0813","article-title":"Sleep disturbance in adults with posttraumatic stress disorder: a review.","volume":"68","author":"Lamarche","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R45-3-20210129","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1469-8986.2007.537.x","article-title":"Polysomnographically measured sleep abnormalities in PTSD: a meta-analytic review.","volume":"44","author":"Kobayashi","year":"2007","journal-title":"Psychophysiology"},{"key":"R46-3-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopsych.2007.07.001","article-title":"Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.","volume":"63","author":"Taylor","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R47-3-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/JCP.0b013e3181dac52f","article-title":"Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans: an assessment of long-term comparative effectiveness and safety.","volume":"30","author":"Byers","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R48-3-20210129","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1176\/appi.ajp.2008.08111697","article-title":"Chest pain in a young patient treated with prazosin for PTSD.","volume":"166","author":"Nuzhat","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R49-3-20210129","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/appi.ajp.162.3.578","article-title":"Comparison of large versus smaller trials for mental-health interventions.","volume":"162","author":"Contopoulos-Ioannidis","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R50-3-20210129","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/sleep\/33.12.1633","article-title":"Sleep symptoms predict the development of the metabolic syndrome.","volume":"33","author":"Troxel","year":"2010","journal-title":"Sleep"},{"key":"R52-3-20210129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/JCP.0b013e3181c827ae","article-title":"Doxazosin treatment for posttraumatic stress disorder.","volume":"30","author":"De Jong","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R53-3-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00004714-199608000-00004","article-title":"Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design.","volume":"16","author":"Hertzberg","year":"1996","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"R54-3-20210129","first-page":"1","article-title":"NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults.","volume":"22","author":"Leshner","year":"2005","journal-title":"NIH Consens State Sci Statements"},{"key":"R55-3-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2001-15871","article-title":"Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares.","volume":"34","author":"Warner","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"R57-3-20210129","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S1092852900024020","article-title":"Mechanism of action of trazodone: a multifunctional drug.","volume":"14","author":"Stahl","year":"2009","journal-title":"CNS Spectr"},{"key":"R58-3-20210129","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1099-1077(199804)13:3<191::AID-HUP972>3.0.CO;2-X","article-title":"Subjective hypnotic efficacy of trazodone and zolpidem in DSM III-R primary insomnia.","volume":"13","author":"Walsh","year":"1998","journal-title":"Hum Psychopharmacol"},{"key":"R59-3-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sleep.2003.06.006","article-title":"The effects of trazodone on sleep in patients treated with stimulant antidepressants.","volume":"5","author":"Kaynak","year":"2004","journal-title":"Sleep Med"},{"key":"R60-3-20210129","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1176\/ajp.151.7.1069","article-title":"Trazodone for antidepressant-associated insomnia.","volume":"151","author":"Nierenberg","year":"1994","journal-title":"Am J Psychiatry"},{"key":"R61-3-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1990.01810150059010","article-title":"Treatment of posttraumatic stress disorder with amitriptyline and placebo.","volume":"47","author":"Davidson","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"R62-3-20210129","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-199106000-00011","article-title":"Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine.","volume":"179","author":"Kosten","year":"1991","journal-title":"J Nerv Ment Dis"},{"key":"R63-3-20210129","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4088\/JCP.v69n1005","article-title":"Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.","volume":"69","author":"Scharf","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R64-3-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004714-200210000-00012","article-title":"Tolerance to daytime sedative effects of H1 antihistamines.","volume":"22","author":"Richardson","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"R65-3-20210129","first-page":"236","article-title":"Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment.","volume":"51","author":"Braun","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"R66-3-20210129","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1517\/14728210902972494","article-title":"Post-traumatic stress disorder: emerging concepts of pharmacotherapy.","volume":"14","author":"Baker","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"R67-3-20210129","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.09m05607gry","article-title":"Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.","volume":"72","author":"Pollack","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R68-3-20210129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1345\/aph.1L320","article-title":"Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions.","volume":"43","author":"Wine","year":"2009","journal-title":"Ann Pharmacother"},{"key":"R69-3-20210129","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4088\/JCP.08r04392","article-title":"Are weight gain and metabolic side effects of atypical antipsychotics dose dependent A literature review.","volume":"70","author":"Simon","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R70-3-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1592\/phco.30.10.1011","article-title":"Statistically significant increase in weight caused by low-dose quetiapine.","volume":"30","author":"Williams","year":"2010","journal-title":"Pharmacotherapy"},{"key":"R72-3-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-200302000-00003","article-title":"Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy.","volume":"23","author":"Hamner","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R73-3-20210129","first-page":"16","article-title":"Real-world data on SSRI antidepressant side effects.","volume":"6","author":"Cascade","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"R74-3-20210129","first-page":"25","article-title":"Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines.","volume":"14","author":"Stein","year":"2009","journal-title":"CNS Spectr"},{"key":"R75-3-20210129","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.","volume":"283","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"R76-3-20210129","first-page":"135","article-title":"Can physiologic assessment and side effects tease out differences in PTSD trials A double-blind comparison of citalopram, sertraline, and placebo.","volume":"37","author":"Tucker","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"R77-3-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4088\/JCP.v63n0305","article-title":"Fluoxetine versus placebo in posttraumatic stress disorder.","volume":"63","author":"Martenyi","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R78-3-20210129","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.euroneuro.2005.10.007","article-title":"Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: analysis of the veteran group of a placebo-controlled, randomized clinical trial.","volume":"16","author":"Martenyi","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"R79-3-20210129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/JCP.0b013e31803308ce","article-title":"Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study.","volume":"27","author":"Martenyi","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R80-3-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1017\/S1461145700001899","article-title":"Open trial of citalopram in adults with post-traumatic stress disorder.","volume":"3","author":"Seedat","year":"2000","journal-title":"Int J Neuropsychopharmacol"},{"key":"R81-3-20210129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.jcp.0000195043.39853.bc","article-title":"Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: an open trial.","volume":"26","author":"English","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R82-3-20210129","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4088\/JCP.v67n1005","article-title":"Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.","volume":"67","author":"Robert","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R83-3-20210129","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00004714-199810000-00005","article-title":"Bupropion treatment in veterans with posttraumatic stress disorder: an open study.","volume":"18","author":"Canive","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R84-3-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/JCP.0b013e318032eaed","article-title":"A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder.","volume":"27","author":"Becker","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R85-3-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/hup.426","article-title":"Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study.","volume":"17","author":"Bahk","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"R86-3-20210129","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hup.615","article-title":"Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial.","volume":"19","author":"Chung","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"R87-3-20210129","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-3223(02)01411-7","article-title":"Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.","volume":"53","author":"Davidson","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R88-3-20210129","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1440-1819.2005.01447.x","article-title":"The effectiveness of mirtazapine in the treatment of post-traumatic stress disorder: a 24-week continuation therapy.","volume":"59","author":"Kim","year":"2005","journal-title":"Psychiatry Clin Neurosci"},{"key":"R90-3-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4088\/JCP.v60n0106","article-title":"Psychotic symptoms in combat-related posttraumatic stress disorder.","volume":"60","author":"David","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R92-3-20210129","first-page":"1","article-title":"Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms.","volume":"18","author":"Hamner","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"R93-3-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.v69n0402","article-title":"Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.","volume":"69","author":"Rothbaum","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R94-3-20210129","first-page":"451","article-title":"Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder.","volume":"175","author":"Pivac","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"R95-3-20210129","first-page":"69","article-title":"An open-label assessment of aripiprazole in the treatment of PTSD.","volume":"42","author":"Robert","year":"2009","journal-title":"Psychopharmacol Bull"},{"key":"R97-3-20210129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1997.tb48274.x","article-title":"Noradrenergic alterartions in posttraumatic stress disorder.","volume":"821","author":"Southwick","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"R98-3-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1017\/S1461145708009164","article-title":"Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers.","volume":"12","author":"Murphy","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R99-3-20210129","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1176\/ajp.146.4.513","article-title":"A controlled trial of desipramine in 18 men with posttraumatic stress disorder.","volume":"146","author":"Reist","year":"1989","journal-title":"Am J Psychiatry"},{"key":"R100-3-20210129","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archpsyc.63.10.1158","article-title":"Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.","volume":"63","author":"Davidson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R101-3-20210129","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.jcp.0000222514.71390.c1","article-title":"Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.","volume":"26","author":"Davidson","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"R102-3-20210129","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.4088\/JCP.v69n1002","article-title":"A pooled analysis of gender and trauma-type effects on responsiveness to treatment of PTSD with venlafaxine extended release or placebo.","volume":"69","author":"Rothbaum","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R103-3-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S1461145708008961","article-title":"Onset of activity and time to response on individual CAPS-SX17 items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis.","volume":"12","author":"Stein","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"R104-3-20210129","first-page":"2","article-title":"Nefazedone hepatotoxicity: black box warning.","volume":"25","author":"Gelenberg","year":"2002","journal-title":"Biol Ther Psychiatry"},{"key":"R105-3-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004714-200004000-00007","article-title":"Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.","volume":"20","author":"Davis","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"R106-3-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1011148304140","article-title":"Open trial of nefazodone for combat veterans with posttraumatic stress disorder.","volume":"14","author":"Garfield","year":"2001","journal-title":"J Trauma Stress"},{"key":"R107-3-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.jcp.0000125685.82219.1a","article-title":"A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.","volume":"24","author":"Davis","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R108-3-20210129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/da.20008","article-title":"Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.","volume":"19","author":"McRae","year":"2004","journal-title":"Depress Anxiety"},{"key":"R109-3-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-199903000-00001","article-title":"Nefazodone in post-traumatic stress disorder: results from six open-label trials.","volume":"14","author":"Hidalgo","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"R110-3-20210129","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4088\/JCP.v59n0904","article-title":"Open trial of nefazodone for combat-related posttraumatic stress disorder.","volume":"59","author":"Hertzberg","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"R111-3-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/10401230209147460","article-title":"Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.","volume":"14","author":"Hertzberg","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"R112-3-20210129","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4088\/JCP.v61n0310","article-title":"Nefazodone in patients with treatment-refractory posttraumatic stress disorder.","volume":"61","author":"Zisook","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R113-3-20210129","first-page":"361","article-title":"Valproate in combat-related posttraumatic stress disorder.","volume":"52","author":"Fesler","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"R114-3-20210129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/JCP.0b013e318160f83b","article-title":"Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.","volume":"28","author":"Davis","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R115-3-20210129","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0006-3223(99)00011-6","article-title":"A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder.","volume":"45","author":"Hertzberg","year":"1999","journal-title":"Biol Psychiatry"},{"key":"R116-3-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4088\/JCP.v68n0204","article-title":"Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.","volume":"68","author":"Tucker","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R117-3-20210129","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/jcp.0b013e31815a43ee","article-title":"A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.","volume":"27","author":"Lindley","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R118-3-20210129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4088\/JCP.v67n0206","article-title":"Levetiracetam for treatment-refractory posttraumatic stress disorder.","volume":"67","author":"Kinrys","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R119-3-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-005-0265-3","article-title":"Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment.","volume":"184","author":"Connor","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R120-3-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/JCP.0b013e31802e5115","article-title":"The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.","volume":"27","author":"Davidson","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R121-3-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e32825ea324","article-title":"The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.","volume":"23","author":"Pae","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"R122-3-20210129","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004714-200304000-00012","article-title":"Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder.","volume":"23","author":"Monnelly","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R123-3-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jama.2011.1080","article-title":"Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD.","volume":"306","author":"Krystal","year":"2011","journal-title":"JAMA"},{"key":"R124-3-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.yic.0000182116.49887.ae","article-title":"Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study.","volume":"21","author":"Ahearn","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R125-3-20210129","first-page":"6","article-title":"Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.","volume":"40","author":"Villarreal","year":"2007","journal-title":"Psychopharmacol Bull"},{"key":"R126-3-20210129","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1590\/S1516-44462008000400011","article-title":"Aripiprazole in the treatment of posttraumatic stress disorder: an open-label trial.","volume":"30","author":"Mello","year":"2008","journal-title":"Rev Bras Psiquiatr"},{"key":"R127-3-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-200107000-00003","article-title":"Olanzapine in the treatment of post-traumatic stress disorder: a pilot study.","volume":"16","author":"Butterfield","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"R128-3-20210129","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1176\/appi.ajp.159.10.1777","article-title":"Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.","volume":"159","author":"Stein","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R129-3-20210129","first-page":"430","article-title":"Ziprasidone therapy for post-traumatic stress disorder.","volume":"30","author":"Siddiqui","year":"2005","journal-title":"J Psychiatry Neurosci"},{"key":"R130-3-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death.","volume":"360","author":"Ray","year":"2009","journal-title":"N Engl J Med"},{"key":"R131-3-20210129","first-page":"29","article-title":"Should psychiatrists use atypical antipsychotics to treat nonpsychotic anxiety Psychiatry (Edgmont","volume":"6","author":"Pies","year":"2009","journal-title":")"},{"key":"R132-3-20210129","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00005053-198909000-00005","article-title":"Clonidine in Cambodian patients with posttraumatic stress disorder.","volume":"177","author":"Kinzie","year":"1989","journal-title":"J Nerv Ment Dis"},{"key":"R133-3-20210129","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/JCP.0b013e31819a4bae","article-title":"Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial.","volume":"29","author":"Ziegenhorn","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R134-3-20210129","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1176\/ajp.2006.163.12.2186","article-title":"No improvement of posttraumatic stress disorder symptoms with guanfacine treatment.","volume":"163","author":"Neylan","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R135-3-20210129","first-page":"8","article-title":"A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans.","volume":"41","author":"Davis","year":"2008","journal-title":"Psychopharmacol Bull"},{"key":"R136-3-20210129","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0006-3223(01)01279-3","article-title":"Pilot study of secondary prevention of posttraumatic stress disorder with propranolol.","volume":"51","author":"Pitman","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R137-3-20210129","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0006-3223(03)00412-8","article-title":"Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma.","volume":"54","author":"Vaiva","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R138-3-20210129","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jts.20270","article-title":"Pharmacotherapy to prevent PTSD: results from a randomized controlled proof-of-concept trial in physically injured patients.","volume":"20","author":"Stein","year":"2007","journal-title":"J Trauma Stress"},{"key":"R139-3-20210129","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jpsychires.2007.05.006","article-title":"Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder.","volume":"42","author":"Brunet","year":"2008","journal-title":"J Psychiatr Res"},{"key":"R140-3-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-1781(88)90057-1","article-title":"A controlled trial of phenelzine in posttraumatic stress disorder.","volume":"24","author":"Shestatzky","year":"1988","journal-title":"Psychiatry Res"},{"key":"R141-3-20210129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF02246271","article-title":"A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder.","volume":"122","author":"Baker","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"R142-3-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/anxi.3070010404","article-title":"Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic.","volume":"1","author":"Katz","year":"1994","journal-title":"Anxiety"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.3109\/10673229.2011.614483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:16:38Z","timestamp":1786047398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00023727-201109200-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,20]]},"references-count":129,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.3109\/10673229.2011.614483","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,20]]}}}